血管紧张素Ⅱ受体之间的相互作用及在心血管疾病中的作用
出处
《临床荟萃》
CAS
北大核心
2007年第10期753-755,共3页
Clinical Focus
参考文献18
-
1Kaschina E,Unger T.Angiotensin AT1/AT2 receptors:regulation,signalling and function[J].Blood Press,2003,12(2):70-88.
-
2Nakajima M,Mukoyama M,Pratt RE,et al.Cloning of cDNA and analysis of the gene for mouse angiotensin Ⅱ type 2 receptor[J].Biochem Biophys Res Commun,1993,197(2):393-399.
-
3Kambayashi Y,Bardhan S,Takahashi K,et al.Molecular cloning of a novel angiotensin Ⅱ receptor isoform involved in phosphotyrosine phosphatase inhibition[J].J Biol Chem,1993,268(33):24543-24546.
-
4Perlegas D,Xie H,Sinha S,et al.The angiotensin type-2 receptor regulates smooth muscle growth and force generation in late fetal mouse development[J].Am J Physiol Heart Circ Physiol,2005,288(1):H96-102.
-
5傅向华,孙家安.心力衰竭的现代认识[J].临床荟萃,2004,19(1):55-58. 被引量:11
-
6Widdop RE,Gardiner SM,Kemp PA,et al.Inhibition of the hemodynamic effects of angiotensin Ⅱ in conscious rats by AT2 receptor antagonists given after the AT1 receptor antagonist EXP3074[J].Br J Pharmacol,1992,107(3):873-880.
-
7Savoia C,Ebrahimian T,He Y.Angiotensin Ⅱ/AT2 receptor-induced vasodilation in stroke-prone spontaneously hypertensive rats involves nitric oxide and cGMP-dependent protein kinase[J].Hypertension,2006,24(12):2417-2422.
-
8Barber MN,Sampey DB,Widdop RE.AT2 receptor stimulation enhances antihypertension effect of AT1 receptor antagonist in hypertensive rats[J].Hypertension,1999,34(5):1112-1116.
-
9Tsutsumi Y,Matsubara H,Masaki H,et al.Angiotensin type-2 receptor over expression activates the vascular kinin system and causes vasodilation[J].J Clin Invest,1999,104(7):925-935.
-
10Widdop RE,Jones ES,Hannan RE,et al.Angiotensin AT2 receptors:cardiovascular hope or hype?[J].Br J Pharmacol,2003,140(5):809-824.
二级参考文献10
-
1Weber K T.Aldosterone in congestive heart failure[].The New England Journal of Medicine.2001
-
2Foody J M,Farrell M H,Krumholz H M.Beta-blocker therapy in heart failure: scientific review[].The Journal of The American Medical Association.2002
-
3Sutton M G J,Sharpe N.Left ventricular remodeling after myocardial infarction: pathophysiology and therapy[].Circulation.2000
-
4Otsuji Y,Gilon D,Jiang L,et al.Restricted diastolic opening of the mitral leaflets in patients with left ventricular dysfunction:evidence for increased valve tethering[].Journal of the American College of Cardiology.1998
-
5Stellbrink C,Breithardt O A,Franke A,et al.Impact of cardiac resynchronization therapy using hemodynamically optimized pacing on left ventricular remodeling in patients with congestive heart failure and ventricular conduction disturbances[].Journal of the American College of Cardiology.2001
-
6Gerber T C,Nishimura R A,Holmes D R,et al.Left ventricular and biventricular pacing in congestive heart failure[].Mayo Clinic Proceedings.2001
-
7Stevenson W G,Stevenson L W.Prevention of sudden death in heart failure[].Journal of Cardiovascular Electrophysiology.2001
-
8Banerjee P,Banerjee T,Khand A,et al.Diastolic heart failure:neglected or misdiagnosed?[].Journal of the American College of Cardiology.2002
-
9MORRISON LK,HARRISON A,KRISHNASWAMY P,et al.Utility of a rapid B-natriuretic peptide assay in differentiatingcongestive heart failure from lung disease in patientspresenting with dyspnea[].Journal of the American College of Cardiology.2002
-
10Taegtmeyer H,McNulty P,Young M E.Adaptation and maladaptation of the heart in diabetes[].Circulation.2002
共引文献10
-
1闫启成.卡托普利和美托洛尔治疗慢性心力衰竭的临床观察[J].海南医学,2007,18(8):150-151. 被引量:2
-
2曹永胜.黄芪注射液联合丹参注射液治疗老年慢性心力衰竭的疗效观察[J].河北医学,2007,13(5):618-619.
-
3滕国旗,常广树.心力衰竭预后与干预的临床进展[J].医学理论与实践,2008,21(1):34-36.
-
4赵德芳,赵义.小剂量螺内酯在心力衰竭治疗中的应用[J].中国现代医生,2008,46(8):103-104. 被引量:4
-
5李珍,刘东凤.丹参注射液作用于心血管系统的实验药理学研究[J].亚太传统医药,2009,5(3):46-47. 被引量:1
-
6王跃菠,李世江,张晓岚,李海,陈红波.赖诺普利联合螺内酯治疗慢性充血性心力衰竭30例临床研究[J].中国民族民间医药,2009,18(5):81-82.
-
7于刃锋.复方丹参注射液联合黄芪注射液治疗充血性心力衰竭的临床观察[J].中医杂志,2010,51(S1):180-181. 被引量:2
-
8李克卉,周建辉.人参注射液辅助治疗充血性心力衰竭32例疗效观察[J].山东医药,2009,49(23):62-63. 被引量:2
-
9张周平.丹参注射液卡托普利联用治疗充血性心力衰竭26例[J].实用中医内科杂志,2010,24(9):46-48.
-
10武国霞,郭秀芳.黄芪注射液联合丹参注射液治疗老年慢性心力衰竭的疗效观察[J].贵阳中医学院学报,2013,35(2):110-111. 被引量:1
-
1肖海鹏,苏磊.老年内分泌系统的变化[J].中华内分泌代谢杂志,2014,30(9):809-812. 被引量:5
-
2洪天配.新型口服降糖药DPP-4抑制剂:从胰岛α细胞看2型糖尿病治疗的新进展[J].中国糖尿病杂志,2012,20(7):558-560. 被引量:13
-
3郭晓红,贾永平,吕吉元.血管紧张素Ⅱ1型受体基因变异与心血管疾病[J].中国心血管病研究,2005,3(7):549-551. 被引量:1
-
4吴小脉(综述),龚永生(综述),高钰琪(审校).Apelin的心血管效应[J].国外医学(生理病理科学与临床分册),2005,25(2):123-126. 被引量:1
-
5许丹,刘昌慧,郝亚容.尾加压素Ⅱ在心血管疾病中的研究进展[J].高血压杂志,2005,13(10):608-610. 被引量:2
-
6魏源.瘦素与运动[J].沈阳体育学院学报,2004,23(6):750-752. 被引量:1
-
7刘超群,浦江,付山峰,李欣,李辉,崔立红.十二指肠溃疡患者血浆肽类胃肠激素变化的初步探讨[J].中华保健医学杂志,2012,14(5):351-353. 被引量:10
-
8陈愉,李胜歧,谭朴泉.粒-巨噬细胞集落刺激因子在肺表面活性物质稳态调节中的作用[J].国外医学(呼吸系统分册),2004,24(4):222-224. 被引量:1
-
9宁光.肠促胰素在血糖稳态调节和2型糖尿病治疗中的作用[J].中华内分泌代谢杂志,2010,26(9):836-839. 被引量:24
-
10李博,李卫华.SREBPs信号转导途径与动脉粥样硬化研究进展[J].心血管病学进展,2011,32(6):876-879. 被引量:3